AzTrials
AzTrials

Ventilation Therapy; ComplicationsABDO-VMNCT04939298

Ultrasound Evaluation of Abdominal Muscle Thickness During Mechanical Ventilation

A study testing Ultrasound in people with Ventilation Therapy; Complications, run by Centre Hospitalier de Roanne at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Weakness of respiratory muscles is frequent after several days of mechanical ventilation. Thereby an acquired diaphragm weakness has been demonstrated, linked to an atrophy which may be identified by a decrease of muscle thickness in echography. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ventilation Therapy; Complications
What is being tested?
Ultrasound
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteFrance
Study dates
15 Jul 2021to 16 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient affiliated or entitled to a social security plan
  • Expected duration of mechanical ventilation > 7 days
  • Trusted person/relative who has signed a consent to participate in the study

Who cannot join

  • Patient with a pre-existing neuromuscular pathology
  • No access to ultrasound Windows (dressing, drainages...)
  • Patient transferred from another intensive care unit
  • Patient Under guardianship or curators

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier de Roanne

    Roanne, 42328

Other trials in France

About this study

Weakness of respiratory muscles is frequent after several days of mechanical ventilation. Thereby an acquired diaphragm weakness has been demonstrated, linked to an atrophy which may be identified by a decrease of muscle thickness in echography. This study aims to evaluate with ultrasound the variation of thickness of abdominal muscles after 7 days of mechanical ventilation.

Read the detailed description

Weakness of respiratory muscles is frequent after several days of mechanical ventilation. Thereby an acquired diaphragm weakness has been demonstrated, linked to an atrophy which may be identified by a decrease of muscle thickness in echography. Weakness of expiratory muscles is also frequent after 7 days of mechanical ventilation, however his cause is not clear: is it present at admission notably in elderly patients, or acquired on mechanical ventilation ? Ultrasound allows to measure the thickness of abdominal muscles which correlates with their strength. This study aims to evaluate with ultrasound the variation of thickness of abdominal muscles after 7 days of mechanical ventilation.

Being tested
Ultrasound
Keywords
abdominal muscles, ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • UltrasoundDevice

    Ultrasound evaluation of the variation of thickness of abdominal muscles after 7 days of mechanical ventilation.

Study groups in NCT04939298
Study groupRoleWhat they receive
Patients under mechanical ventilationExperimentalUltrasound evaluation of the variation of thickness of abdominal muscles after 7 days of mechanical ventilation
Receives: Device: Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Thickness of the abdominal muscles (mm)

    It is the sum of the thickness of rectus abdominal muscle + external oblique + internal oblique + transverse muscles.

    Measured: Day 7

Secondary outcomes (16)
  1. Thickness of the rectus abdominal muscles (mm)

    Thickness of the rectus abdominal muscles (mm) by ultrasound measurement.

    Measured: Day 7

  2. Thickness of the external oblique abdominal muscles (mm)

    Thickness of the external oblique abdominal muscles (mm) by ultrasound measurement

    Measured: Day 7

  3. Thickness of the internal oblique abdominal muscles (mm)

    Thickness of the internal oblique abdominal muscles (mm) by ultrasound measurement

    Measured: Day 7

  4. Thickness of the transverse abdominal muscles (mm)

    Thickness of the transverse abdominal muscles (mm) by ultrasound measurement

    Measured: Day 7

  5. Diaphragmatic thickness (mm)

    Diaphragmatic thickness (mm) measured by ultrasound

    Measured: Day 7

  6. Diaphragmatic thickness (mm)

    Diaphragmatic thickness (mm) measured by ultrasound

    Measured: Immediately after the successful extubation of the patient

  7. Number of day with a contraction of the transverse abdominal muscle

    Ultrasound search for a contraction of the transverse abdominal muscle during the morning clinical examination each day from D1 to D7

    Measured: From day 1 to day 7

  8. Caught peak expiratory flow (CPEF) (cmH2O)

    Only for conscious patients, responding to the simple command and tolerating minimal respiratory support (inspiratory support 7 cmH20, Pep 0 cmH20) caught peak expiratory flow (CPEF) measurement

    Measured: Day 7

  9. Maximum expiratory pressure (l/min)

    Only for conscious patients, responding to the simple command and tolerating minimal respiratory support maximum expiratory pressure (PE max) measurement

    Measured: Day 7

  10. Thickness of the external oblique abdominal muscle (mm)

    External oblique abdominal muscle by ultrasound measurement

    Measured: Immediately after the successful extubation of the patient

  11. Thickness of the internal oblique abdominal muscle (mm)

    Internal oblique abdominal muscle by ultrasound measurement

    Measured: Immediately after the successful extubation of the patient

  12. Thickness of the transverse abdominal muscle (mm)

    Transverse abdominal muscle by ultrasound measurement

    Measured: Immediately after the successful extubation of the patient

  13. Thickness of the rectus abdominal muscle (mm)

    Rectus abdominal muscle by ultrasound measurement

    Measured: Immediately after the successful extubation of the patient

  14. Number of day between day 7 and successful extubation day (days)

    Measured: From Day 7 to the day when the patient will be extubated successfully

  15. Duration of sedation (Day)

    Measured: At intensive care unit discharge

  16. Duration of curarization (Day)

    Measured: At intensive care unit discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2021
  2. Study start15 Jul 2021
  3. Primary completion16 Nov 2023
  4. Study completion16 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04939298
Sponsor's protocol ID
2020/01
Other IDs
2020-A03186-33
Acronym
ABDO-VM
Status last verified
Feb 2024
First submitted
11 Jun 2021
Last updated
7 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound in people with Ventilation Therapy; Complications, run by Centre Hospitalier de Roanne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Thickness of the abdominal muscles (mm) (time frame: Day 7). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in